Nanjing King-Friend Biochemical Pharmaceutical (603707.SH): Rocuronium Bromide Injection Obtains Drug Registration Certificate.
Jianniu Corporation (603707.SH) announced that the company recently received the approval for Rocuronium Bromide issued by the National Medical Products Administration.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) announced that the company has recently received the drug registration certificate for Rocuronium Bromide Injection 5ml:50mg and 10ml:100mg issued by the National Medical Products Administration.
Rocuronium Bromide Injection is used as an adjuvant for general anesthesia, to facilitate tracheal intubation during routine induction of anesthesia, and to maintain neuromuscular blockade of skeletal muscles during surgery.
Related Articles
WEIGAO GROUP (01066) spent 3.1682 million Hong Kong dollars to repurchase 540,000 shares on September 18th.
China Pacific Insurance (02601) completed the issuance of 15.556 billion Hong Kong dollars in bonds.
GLORIOUS SUN (00393) spent 10,300 Hong Kong dollars to repurchase 8,000 shares on September 18.
WEIGAO GROUP (01066) spent 3.1682 million Hong Kong dollars to repurchase 540,000 shares on September 18th.
China Pacific Insurance (02601) completed the issuance of 15.556 billion Hong Kong dollars in bonds.
GLORIOUS SUN (00393) spent 10,300 Hong Kong dollars to repurchase 8,000 shares on September 18.
